자산 1
CLEO ONE
ENG KOR
  • Instrument > Point-of-Care

    CLEO™ ONE

    The CLEO™ ONE system is intended to perform for nucleic acid amplification of samples.
    CLEO™ ONE system is intended for in vitro diagnostic use only.
    The CLEO™ ONE system is a compact molecular amplification instrument with fluorescence detection.


    MFDS License No. : IVD-23-4812

    For more information, please visit www.cleo1.net

    • Specifications
      Model    CLEO™ ONE
      Test capacity    1 test
      Detection channel    1 channel (FAM)
      Reaction chamber    3 well
      Connection    Blooth 5.0
      Test method    Fluorescence-isothermal amplification
      Test sample    Nasal swab
      Operating system    Android OS, iOS
      Power supply    100 - 240V, 50/60Hz, 2A
      Dimensions (LxWxH)    72×72×104 mm (2.8″x2.8″x4.1″)
      Weight    165g (5.8 oz)
       

      CLEO™ ONE App download

           
    • Features
    • Technology

      • Precise Controlled Microfluidic (PCM) technology enables non-experts to perform point-of-care molecular self-tests. ​PCM technology can automatically move the sample to the reagent chamber without electrical or mechanical processes and minimize the volume deviation between tests by controlling liquid flow within the error range of 1 uL. 
      • In addition, PCM technology fundamentally prevents external contamination, resulting in high accuracy and reproducibility.

      • Versatile Fluorescence Sensing (VFS) technology increases the accuracy of molecular diagnosis by reading fluorescence signals at multiple positions.
      • The VFS technology can sensitively measure the fluorescence intensity transmitted from the reaction chambers and perform multiplex analyses of fluorescence signals in real time.
      • The VFS technology can improve both point-of-care tests and self-test quality by achieving sensitivity & specificity comparable to high-performance level tests in the laboratory.
       

              

    • Test Protocol
    • How to use